Mechanisms of mesenchymal stromal cell immunomodulation.
read more
Citations
Burn wound healing and treatment: review and advancements
Species Variation in the Mechanisms of Mesenchymal Stem Cell-Mediated Immunosuppression
MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation
Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning.
Paracrine Mechanisms of Mesenchymal Stem Cells in Tissue Repair
References
Pathogen Recognition and Innate Immunity
Macrophage plasticity and polarization: in vivo veritas
Human mesenchymal stem cells modulate allogeneic immune cell responses
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells.
Related Papers (5)
Human mesenchymal stem cells modulate allogeneic immune cell responses
Frequently Asked Questions (15)
Q2. What are the future works mentioned in the paper "Mechanisms of mesenchymal stromal cell immunomodulation" ?
Further research to define the influence of ongoing pathogenic infections, secondary to GvHD or organ transplantation ( for example ) on MSC activation and function will be essential. Moreover, a paradigm is now evolving that supports the idea that MSCs are receptive to environmental cues and have the potential to orchestrate the reprogramming of immune cells to promote host defence and/or resolve inflammation.
Q3. What is the role of IL-6 in the generation of tolerogenic DCs?
DCs generated in the presence of MSCs produce higher levels of anti-inflammatory cytokines including IL-10 and lower levels of the pro-inflammatory cytokines IL-12 and TNF-a.
Q4. What is the role of MSCs in preventing DC homing?
Most notably, MSCs downregulate the expression of DC maturation markers including major histocompatibility complex (MHC) class II, CD40, CD80 and CD868,76–79 and modulate expression of the lymph node homing chemokine receptor CCR7 in vitro8 and in vivo.80 Moreover, MSCmediated preservation of E-cadherin8 expression by DCs fits with the concept that MSCs may prevent DC homing to the local lymph node.
Q5. What is the role of MSCs in the development of tolerance?
The protection afforded by MSCs in these models is mediated through multiple mechanisms, which in the end lead to the induction or expansion of functionally active Treg and the postulated generation of tolerance.
Q6. What is the role of MSCs in the development of neuroprotective phenotype?
In addition, two separate studies have shown that MSCs impair microglial activation and alternatively activate microglia to produce IGF-1, galectin-3 and to express factors associated with a neuroprotective phenotype.
Q7. What are the key features of DCs that can interfere with their development?
MSCs can interfere with the development of both conventional and plasmacytoid DCs75–77 but also with the key features of DC function; migration, maturation and antigen presentation8 and an array of mechanisms have been implicated in these effects.
Q8. What is the role of MSCs in promoting autoimmune uveitis?
MSCs can induce the generation of antigen-specific Treg and TGF-b was identified as the key mechanism involved,89moreover, this study showed that MSCs inhibit experimental autoimmune uveitis in part through the generation of Tregs.
Q9. What is the role of IL-6 in the formation of tolerogenic DCs?
In further support of a contact-dependent mechanism, Chiesa et al.80 propose that MSCs induce tolerogenic DCs through activation of AKT, which impaired nuclear factor-kB signalling, but could not find a role for secreted IL-10.
Q10. What is the role of IL-10 in the generation of tolerogenic DCs?
a recent publication has shown that mouse embryonic fibroblast-derived MSCs generate a novel population of IL-10-dependent tolerogenic DCs through an IL-10-activated suppressor of cytokine signalling-3 (SOCS-3)dependent mechanism.
Q11. What is the role of MSCs in inflammatory diseases?
Given that MSCs are already being utilised for the treatment of patients in clinical trials, it is imperative that the field gains a better understanding of exactly how MSCs mediate their effects in these different inflammatory disorders to ensure that MSC therapy can be utilised with optimal therapeutic efficacy and safety.
Q12. What are the key limitations for MSC research?
some of the key limitations for MSC research have been the lack of specific markers and useful tracking studies to examine the migration and engraftment of MSCs in vivo.
Q13. What is the role of MSCs in determining the function of the immune system?
it seems that MSCs have the capacity to migrate in response to signals produced by inflamed tissues and these signals may have a role in determining the function of MSCs, be that promotion of pathogen clearance or suppression of inflammation.
Q14. What is the role of IDO and PGE-2 in the polarisation of macrophag?
46,47 Production of IDO and PGE-2 have been implicated in MSC modulation of macrophages,43,44 and MSCs cultured in three-dimensional spheroids also have the capacity to reprogram macrophages through the production of PGE-2.48 Perhaps the most notable studies are those that build a stepwise picture of how MSCs orchestrate macrophage polarisation and the influence the local microenvironment has on that process.
Q15. What is the role of MSCs in the development of immune responses?
it appears that long-term engraftment or even localisation of MSCs (in some cases) at the site of injury is not required for MSC modulation of immune responses and pro-reparative effects.